A/H1N1 vaccine
PreclinicalVaccine
A/H1N1 vaccine is one of 8 biologic programs targeting Narcolepsy. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
9 competitors in Narcolepsy
#DrugCompanyPhaseTrials
1Biaxin
AbbVieApproved
Romazicon
CConrado Roberto Hoffmann Filho
Approved
E2086
EisaiPhase 2
Xyrem
Jazz PharmaceuticalsPreclinical
Wakix
HHarmony Biosciences Management, Inc.
Preclinical
Lu AH69593
LundbeckPhase 1
JZP441
Jazz PharmaceuticalsPhase 1
A/H1N1 vaccine
CCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Narcolepsy1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for A/H1N1 vaccine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details